10x Genomics, Inc. Deferred Tax Assets, Tax Deferred Expense, Other
10x Genomics, Inc. (TXG) had Deferred Tax Assets, Tax Deferred Expense, Other of $2.77 million as of 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Deferred Tax Assets, Net
us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther · last filed 2020-02-27
- 2019-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $2.77M.
- 2018-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $1.62M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Other |
|---|---|
| 2019-12-31 | $2.77M 10-K · filed 2020-02-27 |
| 2018-12-31 | $1.62M 10-K · filed 2020-02-27 |